PESQUISA DE NEOPLASIAS ESOFAGICAS SECUNDARIAS EN LOS PACIENTES CON CANCER DE CABEZA Y CUELLO
Columnista Experta de SIIC Hans Scherübl
en colaboración con
Primera edición en siicsalud:
19 de mayo, 2005
Sección Artículos originales,
subsección
Expertos de Iberoamérica,
página
/des/expertocompleto.php/69595
Especialidad principal:
Oncología
Especialidades relacionadas:
Anatomía Patológica,Cirugía,Diagnóstico por Imágenes,
De Villiers EM, Gunst K, Stein H, Scherubl H. Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences, International Journal of Cancer 109:253-258
Scherubl H, Zeitz M. Esophageal cancer, New England Journal of Medicine 350:1363-1364
Sutter A, Maaser K, Gerst B, Krahn A, Zeitz M, Scherübl H. Activation of ERK1/2 by ligands of the peripheral benzodiazepine receptor (PBR): Inhibition increases sensitivity of esophageal cancer cells to PBR ligands, Biochemical Pharmacology 67:1701-1710
Höpfner M, Maaser K, Theiss A, Lenz M, Sutter A, Kashtan H, von Lampe B, Riecken E-O, Zeitz M, Scherubl H. Hypericin activated by an incoherent light source has photodynamic effects on oesophageal cancer cells, International Journal of Colorectal Diseases 18:239-247
Maaser K, Däubler P, Barthel B, Heine B, von Lampe B, Stein H, Hoffmeister B, Scherer H, Scherubl H. Esophageal squamous cell neoplasia in head and neck cancer patients. Upregulation of COX-2 during carcinogenesis, British Journal of Cancer 88:1217-1222
Scherubl H, Sutter A, Zeitz M. NSAIDs and esophageal cancer, Gastroenterology 125:1875-1876
Grabowski P, Kühnel T, Mühr-Wilkenshoff F, Heine B, Stein H, Höpfner M, Germer C, Scherubl H. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma, British Journal of Cancer 88:115-119
Hopfner M, Sutter A, Gerst B, Zeitz M, Scherubl H. A novel approach in the treatment of neuroendocrine gastrointestinal tumors. Targeting the epidermal growth factor receptor by gefitinib (ZD1839), British Journal of Cancer 89:1766-1775
Maaser K, Grabowski P, Sutter A, Barthel B, Foss HD, Berger G, Carayon P, Kühnel T, Gavish M, Zeitz M, Scherubl H. Overexpression of the peripheral-type benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer, Clinical Cancer Research 8:3205-3209
Scherubl H, Scherer H, Hoffmeister B. Second esophageal cancers in head and neck cancer patients, New England Journal of Medicine 346:1416-1417
Hans Scherübl
